Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma

A combination of Adriamycin (a.k.a. Doxorubicin), Bleomycin, Vinblastine, and Dacarbazine (ABVD) is the most commonly used chemotherapy regime for Hodgkin lymphoma. This highly effective treatment is associated with a significant risk of neutropenia. Various strategies are adopted to counter this co...

Descripción completa

Detalles Bibliográficos
Autores principales: Vakkalanka, Bhanu, Link, Brian K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112508/
https://www.ncbi.nlm.nih.gov/pubmed/21687649
http://dx.doi.org/10.1155/2011/656013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112508/
https://www.ncbi.nlm.nih.gov/pubmed/21687649
http://dx.doi.org/10.1155/2011/656013

Ejemplares similares